Market research and consulting
Custom research and consultancy to answer your business questions
Within prescription medicines, we have therapeutic specialists and experience in a broad range of therapy areas from chronic illnesses to rare diseases.
Consumer health and nutritionals
We combine our knowledge of the pharmaceutical sector with our understanding of patients, physicians and consumers to deliver integrated insights.
We have a wealth of experience with medical devices, in vitro and in vivo diagnostics, imaging equipment and e-health solutions. We use our knowledge of the unique market dynamics and regulatory nature of this sector to improve client understanding.
We also offer real-world insights with our range of cost-effective sydicated solutions:
Immunology, Virology, Oncology, Nephrology, Cardiovascular and others
Our online syndicated tracking programme provides global marketing teams with real-time access to the key dynamics driving their market. Using appropriately designed physician panels, we provide patient chart data for a broad range of therapeutic areas and geographies.
Immunology, Atopic Dermatitis, Chronic Pain, Diabetes, NASH and others
Our patient report series offer fresh insight into the behaviour, attitudes and needs of people living with different types of chronic illness, providing a map of the patient journey from pre-diagnosis to stabilisation.
- Some example case studiesHow we helped our client identify where to play and how to win for their hospital product in India
The challenge:Our client has a hospital care portfolio which is marketed globally. Despite a low per capita use of the product in India, the annual growth rate of usage is among the highest in the world. It was therefore critical for our client to understand which channels they should focus on (where to play) and what points of differentiation would enable them to gain market…read more »How we uncovered unmet needs using social media listening
The challenge: Our client wanted to further their understanding of the impacts a long-term rare skin condition can have on patients by exploring the patient journey. Market research was required to identify opportunities for improving the patient experience and inform the brand strategy for their product. The solution: We began by conducting exploratory research using social media listening to review the online commentary and get…read more »How we helped our client understand current and future combination pricing strategies in the Multiple Myeloma market
The challengeOur client had their product for multiple myeloma (MM) approved in several lines of therapy combined with different backbones. Their product was also being studied in some other indications with additional backbones and was anticipated to receive approval in the coming years. With several other competitive therapies available on the market, including many branded combination products, our client anticipated that payers might start considering…read more »
- Our latest white papersChina: How to strategise and win in the world's fastest changing healthcare market
In this paper, our experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma and propose how to build the market understanding required to launch a brand effectively in this exciting region.read more »Are dual ARVs the new frontier in a maturing HIV market?
Tackling and managing HIV has been one of the pharmaceutical industry’s more distinguished achievements, despite the turbulence and antagonism that marked the early days of AIDS-related R&D and the industry’s relationships with governments, patients and activists.read more »